S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
S&P 500   4,164.00 (+1.29%)
DOW   34,156.69 (+0.78%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
NASDAQ:KIDS

OrthoPediatrics - KIDS Stock Forecast, Price & News

$47.75
-0.07 (-0.15%)
(As of 02/7/2023 04:19 PM ET)
Add
Compare
Today's Range
$47.13
$48.49
50-Day Range
$36.59
$49.77
52-Week Range
$35.67
$60.75
Volume
102,827 shs
Average Volume
133,233 shs
Market Capitalization
$1.09 billion
P/E Ratio
125.66
Dividend Yield
N/A
Price Target
$55.00

OrthoPediatrics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
15.2% Upside
$55.00 Price Target
Short Interest
Bearish
8.97% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.20
Upright™ Environmental Score
News Sentiment
0.58mentions of OrthoPediatrics in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$153,519 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.69) to ($0.62) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.32 out of 5 stars

Medical Sector

241st out of 1,029 stocks

Surgical & Medical Instruments Industry

21st out of 105 stocks

KIDS stock logo

About OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.

Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

KIDS Stock News Headlines

OrthoPediatrics Corp. (NASDAQ:KIDS) EVP Sells $59,750.00 in Stock
OrthoPediatrics (NASDAQ:KIDS) PT Raised to $56.00
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
OrthoPediatrics (NASDAQ:KIDS) Trading Up 5.5% on Analyst Upgrade
Solar Industry at Start of Long Bull Run?
The U.S. solar industry generated nearly $33 billion of private investment in the American economy in 2021 -- and analysts say it looks like the start of a long solar bull market. Leading the way is the just-signed Inflation Reduction Act of 2022. With its generous investment tax credits, the Act is expected to triple U.S. solar energy production over the next 5 years.
See More Headlines
Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

KIDS Company Calendar

Last Earnings
11/03/2021
Today
2/07/2023
Next Earnings (Estimated)
3/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:KIDS
Employees
133
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$55.00
High Stock Price Forecast
$62.00
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+15.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-16,260,000.00
Pretax Margin
3.48%

Debt

Sales & Book Value

Annual Sales
$98.05 million
Book Value
$11.45 per share

Miscellaneous

Free Float
16,139,000
Market Cap
$1.09 billion
Optionable
Not Optionable
Beta
0.89

Key Executives

  • David R. Bailey
    President, Chief Executive Officer & Director
  • Fred L. HiteFred L. Hite
    Director, Chief Operating & Financial Officer
  • Peter F. Armstrong
    Chief Medical Officer
  • Joel Batts
    Senior Vice President-Science & Technology
  • Joseph W. Hauser
    Senior Vice President & General Manager













KIDS Stock - Frequently Asked Questions

Should I buy or sell OrthoPediatrics stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" KIDS shares.
View KIDS analyst ratings
or view top-rated stocks.

What is OrthoPediatrics' stock price forecast for 2023?

5 brokerages have issued twelve-month price objectives for OrthoPediatrics' shares. Their KIDS share price forecasts range from $50.00 to $62.00. On average, they predict the company's stock price to reach $55.00 in the next year. This suggests a possible upside of 15.0% from the stock's current price.
View analysts price targets for KIDS
or view top-rated stocks among Wall Street analysts.

How have KIDS shares performed in 2023?

OrthoPediatrics' stock was trading at $39.73 at the beginning of the year. Since then, KIDS shares have increased by 20.4% and is now trading at $47.82.
View the best growth stocks for 2023 here
.

Are investors shorting OrthoPediatrics?

OrthoPediatrics saw a decline in short interest during the month of January. As of January 15th, there was short interest totaling 1,380,000 shares, a decline of 11.0% from the December 31st total of 1,550,000 shares. Based on an average daily volume of 135,700 shares, the days-to-cover ratio is currently 10.2 days. Currently, 9.0% of the company's stock are short sold.
View OrthoPediatrics' Short Interest
.

When is OrthoPediatrics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 1st 2023.
View our KIDS earnings forecast
.

How were OrthoPediatrics' earnings last quarter?

OrthoPediatrics Corp. (NASDAQ:KIDS) released its quarterly earnings data on Wednesday, November, 3rd. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.13. The business had revenue of $25.08 million for the quarter. OrthoPediatrics had a negative trailing twelve-month return on equity of 5.60% and a net margin of 7.90%.

What guidance has OrthoPediatrics issued on next quarter's earnings?

OrthoPediatrics issued an update on its fourth quarter 2022 earnings guidance on Monday, January, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $31.00 million-$31.00 million, compared to the consensus revenue estimate of $33.18 million.

What is Mark Throdahl's approval rating as OrthoPediatrics' CEO?

15 employees have rated OrthoPediatrics Chief Executive Officer Mark Throdahl on Glassdoor.com. Mark Throdahl has an approval rating of 100% among the company's employees. This puts Mark Throdahl in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OrthoPediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrthoPediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Cisco Systems (CSCO), Walt Disney (DIS), Enterprise Products Partners (EPD) and NVIDIA (NVDA).

When did OrthoPediatrics IPO?

(KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

What is OrthoPediatrics' stock symbol?

OrthoPediatrics trades on the NASDAQ under the ticker symbol "KIDS."

Who are OrthoPediatrics' major shareholders?

OrthoPediatrics' stock is owned by a number of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (4.63%), New York State Common Retirement Fund (2.04%), Allspring Global Investments Holdings LLC (1.14%), Monarch Partners Asset Management LLC (0.20%), Oppenheimer Asset Management Inc. (0.17%) and Oak Ridge Investments LLC (0.12%). Insiders that own company stock include (Reynolds) Marie C Infante, Bernie B Berry III, Bernie B Berry III, Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Gregory A Odle, Harold Ruf, Jennifer N Pritzker, Joseph W Hauser, Mark C Throdahl, Mark C Throdahl, Stephen F Burns and Terry D Schlotterback.
View institutional ownership trends
.

How do I buy shares of OrthoPediatrics?

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OrthoPediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $47.82.

How much money does OrthoPediatrics make?

OrthoPediatrics (NASDAQ:KIDS) has a market capitalization of $1.09 billion and generates $98.05 million in revenue each year. The company earns $-16,260,000.00 in net income (profit) each year or $0.38 on an earnings per share basis.

How many employees does OrthoPediatrics have?

The company employs 133 workers across the globe.

How can I contact OrthoPediatrics?

OrthoPediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The official website for the company is www.orthopediatrics.com. The company can be reached via phone at (574) 268-6379, via email at tbui@theruthgroup.com, or via fax at 574-269-3692.

This page (NASDAQ:KIDS) was last updated on 2/7/2023 by MarketBeat.com Staff